kabutan

M3, Inc.(2413) Summary

2413
TSE Prime
M3, Inc.
1,664.5
JPY
+27.5
(+1.68%)
Mar 13, 3:30 pm JST
10.44
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
1,675
Mar 13, 11:23 pm JST
Summary Chart Historical News Financial Result
PER
24.8
PBR
2.68
Yield
ー%
Margin Trading Ratio
13.36
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,618.5 JPY 10.16 USD
Previous Close Mar 12
1,637.0 JPY 10.29 USD
High Mar 13, 9:02 am
1,693.5 JPY 10.64 USD
Low Mar 13, 9:00 am
1,618.0 JPY 10.16 USD
Volume
6,463,600
Trading Value
0.01T JPY 0.07B USD
VWAP
1655.82 JPY 10.39 USD
Minimum Trading Value
166,450 JPY 1,044 USD
Market Cap
1.13T JPY 7.11B USD
Number of Trades
7,963
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
8,239
1-Year High Aug 7, 2025
48,319
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 321,000 4,904,100 15.28
Feb 27, 2026 314,200 4,963,000 15.80
Feb 20, 2026 261,300 5,013,900 19.19
Feb 13, 2026 251,900 4,889,100 19.41
Feb 6, 2026 236,100 4,729,000 20.03
Company Profile
M3, Inc. is a Sony Group affiliate specializing in pharmaceutical marketing support. It provides information through a website for physicians and is also involved in telemedicine.
Sector
Services
M3, Inc., a member of the Sony Group, aims to revolutionize the medical world through the use of the internet. The company operates various services both domestically and internationally, centered around its professional medical website "m3.com". Its main business activities include marketing support for medical-related companies, surveys targeting healthcare professionals, practice management services, clinical trial support, CSO operations, and the development and sale of electronic medical records. M3 also engages in evidence solution services such as clinical development support, clinical trial management and operational support, and subject recruitment assistance. Additionally, the company provides human resource services for medical professionals, management support for medical institutions, and operates hospice facilities. Internationally, M3 has expanded its operations globally, offering marketing support, surveys, human resource services for medical professionals, and clinical trial support.